New antibodies target “dark side” of influenza virus protein
New antibodies target “dark side” of influenza virus protein NIH researchers explore hidden, vulnerable region…
News Releases
News Releases
Tools underestimate cardiovascular event risk in people with HIV
Tools underestimate cardiovascular event risk in people with HIV NIH trial reveals need for more…
News Releases
Semaglutide reduces severity of common liver disease in people with HIV
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
News Releases
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy Multi-country findings…
News Releases
Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed HIV
Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed…
News Releases
Children surpass a year of HIV remission after treatment pause
Children surpass a year of HIV remission after treatment pause NIH-funded trial shows promising outcomes…
News Releases
NIH scientists find weak points on Epstein-Barr virus
NIH scientists find weak points on Epstein-Barr virus New details of EBV protein could aid…
News Releases
Experimental NIH malaria monoclonal antibody protective in Malian children
Experimental NIH malaria monoclonal antibody protective in Malian children Mid-stage trial shows treatment prevents infection,…
News Releases
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard…
News Releases
NIH study shows chronic wasting disease unlikely to move from animals to people
NIH study shows chronic wasting disease unlikely to move from animals to people Study of…